Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/28170
Title: Investigation into the roles of Ataxia Telangiectasia mutated gene product, in multiple BRCA backgrounds
Authors: HIONG KUM CHEW
Keywords: ATM, BAC recombineering, RNA interference, Irradiation, Etoposide, Chk2
Issue Date: 16-May-2008
Source: HIONG KUM CHEW (2008-05-16). Investigation into the roles of Ataxia Telangiectasia mutated gene product, in multiple BRCA backgrounds. ScholarBank@NUS Repository.
Abstract: ATM is a serine-threonine kinase that is activated in response to DNA double strand breaks and is an important sensor for proper repair. Recent investigations reveal that Ataxia-telangiectasia (AT) mutation carriers have an increased risk of developing breast cancer, especially in younger women. To understand further the interplay between ATM and breast cancer susceptibility genes, we initiated studies to investigate the contribution of simultaneous loss of ATM and BRCA function in multiple cell culture based models. We utilized various approaches to investigate the role of ATM in multiple BRCA backgrounds including RNA interference, clonogenic survival and Bacterial Artificial Chromosome engineering to study downstream signaling efficiency, sensitivity to therapy, cell cycling and transformability. Our data suggests that ATM may regulate other signaling pathways via its ability to interact with BRCA1 and/or BRCA2 and that loss of multiple functions could drive cellular transformation and influence responses to therapy.
URI: http://scholarbank.nus.edu.sg/handle/10635/28170
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Hiong Kum Chew (Physiology) Roles of ATM gene product in multiple BRCA backgrounds (2007).pdf1.46 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

247
checked on Dec 11, 2017

Download(s)

152
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.